219 related articles for article (PubMed ID: 17982407)
1. Complete remission of multiple myeloma.
Lonial S
Clin Adv Hematol Oncol; 2007 Sep; 5(9):671-2, 675. PubMed ID: 17982407
[No Abstract] [Full Text] [Related]
2. [Multiple myeloma: the therapeutic options].
Sánchez Fayos J; Prieto E; Roman A; Olavarria E
An Med Interna; 1992 Feb; 9 Spec No():112-8. PubMed ID: 1550902
[No Abstract] [Full Text] [Related]
3. Supportive therapies in the management of myeloma.
Ludwig H;
Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
[No Abstract] [Full Text] [Related]
4. Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma.
Braiteh F; Hymes SR; Giralt SA; Jones R
J Clin Oncol; 2008 Sep; 26(27):4511-3. PubMed ID: 18802165
[No Abstract] [Full Text] [Related]
5. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
Shimizu K;
Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
[No Abstract] [Full Text] [Related]
6. Myeloma--new approaches to combined nephrological-haematological management.
Haubitz M; Peest D
Nephrol Dial Transplant; 2006 Mar; 21(3):582-90. PubMed ID: 16396976
[No Abstract] [Full Text] [Related]
7. Guidelines on the diagnosis and management of multiple myeloma 2005.
Smith A; Wisloff F; Samson D; ; ;
Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
[No Abstract] [Full Text] [Related]
8. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
9. Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma.
Moreau P
Expert Rev Anticancer Ther; 2009 Jul; 9(7):885-90. PubMed ID: 19589027
[TBL] [Abstract][Full Text] [Related]
10. Complete remission of multiple myeloma after autoimmune hemolytic anemia: possible association with interferon-alpha.
Gesundheit B; Zelig O; Shapira MY; Ackerstein A; Avgil M; Or R
Am J Hematol; 2007 Jun; 82(6):489-92. PubMed ID: 17236186
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the diagnosis and management of multiple myeloma 2011.
Bird JM; Owen RG; D'Sa S; Snowden JA; Pratt G; Ashcroft J; Yong K; Cook G; Feyler S; Davies F; Morgan G; Cavenagh J; Low E; Behrens J;
Br J Haematol; 2011 Jul; 154(1):32-75. PubMed ID: 21569004
[No Abstract] [Full Text] [Related]
12. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Lahuerta JJ; Mateos MV; Martínez-López J; Rosiñol L; Sureda A; de la Rubia J; García-Laraña J; Martínez-Martínez R; Hernández-García MT; Carrera D; Besalduch J; de Arriba F; Ribera JM; Escoda L; Hernández-Ruiz B; García-Frade J; Rivas-González C; Alegre A; Bladé J; San Miguel JF
J Clin Oncol; 2008 Dec; 26(35):5775-82. PubMed ID: 19001321
[TBL] [Abstract][Full Text] [Related]
13. [Current aspects of treatment of multiple myeloma].
Tribalto M; Avvisati G; Cantonetti M; Catalano G; Giovangrossi P; Masi M; Petrucci MT; Venditti A; Papa G
Ann Ital Med Int; 1988; 3(3):193-202. PubMed ID: 3152856
[No Abstract] [Full Text] [Related]
14. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
15. Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
Terpos E; Dimopoulos MA
Lancet Oncol; 2010 Oct; 11(10):913-4. PubMed ID: 20863760
[No Abstract] [Full Text] [Related]
16. Simultaneous presentation and following remission of chronic lymphocytic leukemia and multiple myeloma.
Bernardeschi P; Bonechi I; Marchetti G; Puglisi R
Recenti Prog Med; 1995 Jan; 86(1):25. PubMed ID: 7709037
[No Abstract] [Full Text] [Related]
17. Managing renal complications in multiple myeloma.
Fotiou D; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
[TBL] [Abstract][Full Text] [Related]
18. Nonsecretory multiple myeloma.
Abdalla IA; Tabbara IA
South Med J; 2002 Jul; 95(7):761-4. PubMed ID: 12144086
[TBL] [Abstract][Full Text] [Related]
19. The refractory patient: new treatment options.
Schuster MW
Oncology (Williston Park); 2003 Oct; 17(10):1333-5. PubMed ID: 14606360
[No Abstract] [Full Text] [Related]
20. Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma.
Rostagno C; Ciolli S
Ann Hematol; 2006 Sep; 85(9):627-8. PubMed ID: 16705455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
